Literature DB >> 16457965

Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.

Wim Ceelen1, Peter Smeets, Walter Backes, Nancy Van Damme, Tom Boterberg, Pieter Demetter, Isabel Bouckenooghe, Marieke De Visschere, Marc Peeters, Piet Pattyn.   

Abstract

PURPOSE: To examine dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with a macromolecular contrast agent (P792) to visualize effects of radiotherapy (RT) on microvascular leakage in a colorectal cancer model. METHODS AND MATERIALS: CC531 tumors were induced in WAG/Rij rats. DCE-MRI was performed before and 5 days after 5 x 5 Gy of RT and parametric maps generated of the endothelial transfer constant (K(trans)) and the fractional interstitial space (Ve) according to the Tofts model. Tissue pO2 mapping was performed in each tumor core and rim before and after RT. Microvessel density (MVD), vascular endothelial growth factor (VEGF) expression, and pimonidazole hypoxia staining were compared with a control group of tumor-bearing rats.
RESULTS: Mean K(trans) and v(e) were significantly reduced after RT in all tumor regions. Mean pO2 was 6.8 mm Hg before RT vs. 7.7 mm Hg after RT (p < 0.001) in the tumor rim and 3.5 mm Hg before RT vs. 4.4 mm Hg after RT (p < 0.001) in the tumor core. Mean MVD in the tumor rim was 10.4 in the RT treated group vs. 16.9 in the control group (p = 0.061). VEGF expression was significantly higher in RT-treated rats. After RT, no correlation was found between DCE-MRI parameters and histologic parameters. A correlation was seen after RT between pO2 and K(trans) (r = -0.57, p = 0.08) and between pO2 and v(e) (r = -0.65, p = 0.04).
CONCLUSIONS: Dynamic contrast-enhanced-MRI with P792 allows quantification of microvascular changes in this colorectal model. RT significantly reduces neovascular leakage and enhances tissue oxygenation and VEGF expression. After RT, DCE-MRI parameters are related to tumor pO2, but not to MVD or VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457965     DOI: 10.1016/j.ijrobp.2005.10.026

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

Review 1.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.

Authors:  James P B O'Connor; Alan Jackson; Geoff J M Parker; Caleb Roberts; Gordon C Jayson
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

Review 2.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

3.  Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: theory, simulations, and experimental results.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Laura M DeBusk; P Charles Lin; John C Gore
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

4.  The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.

Authors:  David L Schwartz; Garth Powis; Arun Thitai-Kumar; Yi He; James Bankson; Ryan Williams; Robert Lemos; Junghwan Oh; Andrei Volgin; Suren Soghomonyan; Ryuichi Nishii; Mian Alauddin; Uday Mukhopadhay; Zhenghong Peng; William Bornmann; Juri Gelovani
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

5.  Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI.

Authors:  Dieter De Naeyer; Yves De Deene; Wim P Ceelen; Patrick Segers; Pascal Verdonck
Journal:  MAGMA       Date:  2011-01-08       Impact factor: 2.310

6.  Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.

Authors:  Louke J Delrue; Veerle Casneuf; Nancy Van Damme; Peter Blanckaert; Marc Peeters; Wim P Ceelen; Philippe C O Duyck
Journal:  MAGMA       Date:  2011-05-13       Impact factor: 2.310

7.  Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.

Authors:  Minfeng Chen; Xueping Lei; Changzheng Shi; Maohua Huang; Xiaobo Li; Baojian Wu; Zhengqiu Li; Weili Han; Bin Du; Jianyang Hu; Qiulin Nie; Weiqian Mai; Nan Ma; Nanhui Xu; Xinyi Zhang; Chunlin Fan; Aihua Hong; Minghan Xia; Liangping Luo; Ande Ma; Hongsheng Li; Qiang Yu; Heru Chen; Dongmei Zhang; Wencai Ye
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

Review 8.  In Vivo Application of Proton-Electron Double-Resonance Imaging.

Authors:  Shun Kishimoto; Murali C Krishna; Valery V Khramtsov; Hideo Utsumi; David J Lurie
Journal:  Antioxid Redox Signal       Date:  2017-11-13       Impact factor: 8.401

9.  Arterial perfusion imaging-defined subvolume of intrahepatic cancer.

Authors:  Hesheng Wang; Reza Farjam; Mary Feng; Hero Hussain; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-07       Impact factor: 7.038

Review 10.  Photoacoustic Imaging in Tissue Engineering and Regenerative Medicine.

Authors:  Binita Shrestha; Frank DeLuna; Mark A Anastasio; Jing Yong Ye; Eric M Brey
Journal:  Tissue Eng Part B Rev       Date:  2020-01-14       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.